Gammagard Liquid Baxter Healthcare Corporation - Treatment for Primary Immunodeficiency DisordersGammagard Liquid 10% is a ready-to-use, sterile preparation of highly purified and concentrated immunoglobulin G (IgG) antibodies. Gammagard Liquid is indicated for the treatment of primary immunodeficiency disorders associated with defects in humoral immunity.
Posted: May 2005
- Baxter Announces FDA Approval for Gammagard Liquid as a Treatment for Multifocal Motor Neuropathy - June 26, 2012
- Baxter Announces FDA Approval of Subcutaneous Route of Administration for Gammagard Liquid for Patients with Primary Immunodeficiency - July 25, 2011